封面
市場調查報告書
商品編碼
1800188

全球注射器市場:2025-2030 年預測

Global Syringe Market - Forecasts fom 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計注射器市場規模將從 2025 年的 104.91 億美元成長至 2030 年的 151.48 億美元,複合年成長率為 7.62%。

受慢性病發病率上升和人口快速老化的推動,注射器市場預計將經歷顯著成長。注射器需求的成長與常規醫療介入的需求密切相關,例如糖尿病患者的胰島素注射以及其他慢性病患者的藥物輸送。此外,全球疫苗接種計劃的增加以及人們對其重要性的認知不斷提高,也進一步推動了市場擴張。儘管高昂的製造成本和複雜的供應鏈等挑戰可能會阻礙成長,但強勁的需求仍支撐著市場,尤其是在疾病高發且醫療保健體系發達的地區,例如美國。

主要成長要素

慢性病盛行率上升

全球慢性病(尤其是糖尿病、心血管疾病和癌症)盛行率的上升是注射器市場的主要驅動力。頻繁注射(例如用於糖尿病管理的胰島素)的需求顯著推動了注射器的需求。心血管疾病、癌症和慢性呼吸系統疾病等非傳染性疾病(NCD)的盛行率不斷上升,進一步推動了治療和管理通訊協定中對注射器的需求。由於生活方式因素和全球醫療保健涵蓋範圍的擴大,預計這一趨勢將持續下去。

人口老化

全球老年人口的成長對市場成長做出了重大貢獻,因為老年人更容易患上需要注射治療的慢性疾病。隨著全球老年人口的增加,用於藥物管理和疾病管理的注射器的需求預計會增加,特別是對於糖尿病和類風濕性關節炎等需要定期注射的疾病。

增加疫苗接種計劃

在全球範圍內,疫苗接種在疾病預防中的作用日益受到重視,疫苗接種計畫也隨之擴展,從而推動了注射器的需求。這些計畫得到了政府和醫療機構的支持,凸顯了對安全高效注射器解決方案的需求,隨著越來越多的人尋求預防感染疾病和慢性病,注射器市場的需求將進一步成長。

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 經營狀況

  • 市場促進因素
  • 市場限制
  • 市場機會
  • 波特五力分析
  • 產業價值鏈分析
  • 政策法規
  • 策略建議

第4章 技術展望

第5章全球注射器市場(按類型)

  • 介紹
  • 胰島素注射器
  • 一次性注射器
    • 傳統注射器
      • 偏心尖注射器
      • 導管頭注射器
      • 魯爾鎖注射器
    • 安全注射器
    • 預填充注射器
  • 其他

第6章全球注射器市場(按材料)

  • 介紹
  • 玻璃
  • 塑膠
  • 防鏽的

第7章 全球注射器市場(依注射器尺寸)

  • 介紹
  • 小容量注射器
  • 大容量注射器

第8章全球注射器市場(按地區)

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 台灣
    • 泰國
    • 印尼
    • 其他

第9章競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第10章:公司簡介

  • Becton, Dickinson and Company
  • B. Braun Melsungen
  • Terumo
  • Teleflex
  • Nipro
  • ICU Medical
  • Cardinal Health
  • HMD Healthcare
  • Hamilton Company
  • Advancecare Pharma USA
  • Baxter International

第11章 附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061611594

The global syringe market is expected to grow from USD 10.491 billion in 2025 to USD 15.148 billion in 2030, at a CAGR of 7.62%.

The global syringe market is poised for significant growth, driven by the increasing prevalence of chronic diseases and a rapidly aging population. The rising demand for syringes is closely tied to the need for regular medical interventions, such as insulin administration for diabetes and drug delivery for other chronic conditions. Additionally, growing global immunization programs and heightened awareness of their importance further propel market expansion. While challenges such as high production costs and supply chain complexities may hinder growth, the market is supported by robust demand, particularly in regions with high disease prevalence and advanced healthcare systems like the United States.

Key Growth Drivers

Rising Prevalence of Chronic Diseases

The global increase in chronic diseases, particularly diabetes, cardiovascular conditions, and cancer, is a major driver of the syringe market. The need for frequent injections, such as insulin for diabetes management, significantly boosts syringe demand. The growing incidence of non-communicable diseases (NCDs), including cardiovascular illnesses, cancers, and chronic respiratory conditions, further fuels the need for syringes in treatment and management protocols. This trend is expected to continue, driven by lifestyle factors and increasing healthcare access worldwide.

Aging Population

The global rise in the geriatric population significantly contributes to market growth, as elderly individuals are more prone to chronic conditions requiring injectable treatments. With aging populations increasing worldwide, the demand for syringes for drug administration and disease management is expected to rise, particularly for conditions like diabetes and rheumatoid arthritis, which often necessitate regular injections.

Growing Immunization Programs

Increased global awareness of immunization's role in preventing diseases has led to expanded vaccination programs, driving syringe demand. These programs, supported by governments and health organizations, emphasize the need for safe and efficient syringe solutions, further bolstering market growth as populations seek protection against infectious and chronic diseases.

Market Segmentation

By Geography

The syringe market is segmented into North America, South America, Europe, the Middle East and Africa, and Asia-Pacific. The United States is a key market, driven by the high prevalence of chronic diseases like diabetes and cancer, which require frequent syringe use for treatments such as insulin injections and chemotherapy. The country's advanced healthcare infrastructure and focus on innovation further support market growth. Asia-Pacific is expected to witness rapid expansion due to increasing healthcare investments and a growing patient pool in countries like India and China.

Competitive Landscape

Key players, such as Terumo Pharmaceutical Solutions and Nephron Pharmaceuticals Corporation, are driving innovation in the syringe market. These companies focus on developing advanced syringe solutions, such as polymer and cyclic olefin copolymer (COC) syringes, tailored for high-viscosity biotech drugs and improved durability, meeting the evolving needs of the healthcare industry.

The global syringe market is set for robust growth, propelled by the rising prevalence of chronic diseases, an aging population, and expanding immunization programs. The United States leads due to its high disease burden and advanced healthcare systems, while Asia-Pacific shows strong growth potential. Despite challenges like production costs, innovations in syringe design and materials by key players ensure the market's positive trajectory, addressing critical needs in chronic disease management and vaccination efforts.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2020 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Type

  • Insulin Syringe
  • Disposable Syringes
  • Conventional Syringe
  • Eccentric Tip Syringe
  • Catheter Tip Syringe
  • Luer Lock Syringe
  • Safety Syringes
  • Prefilled Syringes
  • Others

By Material

  • Glass
  • Plastic
  • Stainless Steel

By Syringe Size

  • Smaller Volume Syringe
  • Larger Volume Syringe

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL SYRINGE MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Insulin Syringe
  • 5.3. Disposable Syringes
    • 5.3.1. Conventional Syringe
      • 5.3.1.1. Eccentric Tip Syringe
      • 5.3.1.2. Catheter Tip Syringe
      • 5.3.1.3. Luer Lock Syringe
    • 5.3.2. Safety Syringes
    • 5.3.3. Prefilled Syringes
  • 5.4. Others

6. GLOBAL SYRINGE MARKET BY MATERIAL

  • 6.1. Introduction
  • 6.2. Glass
  • 6.3. Plastic
  • 6.4. Stainless Steel

7. GLOBAL SYRINGE MARKET BY SYRINGE SIZE

  • 7.1. Introduction
  • 7.2. Smaller Volume Syringe
  • 7.3. Larger Volume Syringe

8. GLOBAL SYRINGE MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Others
  • 8.5. Middle East & Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Taiwan
    • 8.6.6. Thailand
    • 8.6.7. Indonesia
    • 8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Becton, Dickinson and Company
  • 10.2. B. Braun Melsungen
  • 10.3. Terumo
  • 10.4. Teleflex
  • 10.5. Nipro
  • 10.6. ICU Medical
  • 10.7. Cardinal Health
  • 10.8. HMD Healthcare
  • 10.9. Hamilton Company
  • 10.10. Advancecare Pharma USA
  • 10.11. Baxter International

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations